NSWRC(SH:600165) Zheng Quan Zhi Xing·2025-05-22 10:21Core Viewpoint - Ningxia Zhongke Biotechnology Co., Ltd. is facing significant financial distress, with a total debt of 2.164 billion yuan and overdue debts amounting to 1.81 billion yuan, leading to a serious risk of bankruptcy [1][5]. Group 1: Debt and Financial Status - The company's total debt scale is 2.164 billion yuan, with overdue debts totaling 1.81 billion yuan and litigation-related debts amounting to 1.26 billion yuan [1][5]. - Most of the company's bank accounts, except for those of its subsidiary Ningxia Huahui Environmental Technology Co., Ltd. and its wholly-owned subsidiary Ningxia Tianfu Activated Carbon Co., Ltd., are frozen, severely impacting its liquidity [1][5]. - Although the bank accounts of Zhongke New Materials Co., Ltd. have been unfrozen, the company is currently lacking sufficient funds and liquid assets to repay its debts, indicating a significant risk to its ongoing operations [1][5]. Group 2: Litigation Status - The company is a defendant in multiple lawsuits, including disputes over loan contracts, equity transfer contracts, sales contracts, construction contracts, and securities fraud [2][5]. - A recent court ruling from the Guangdong Zhanjiang Intermediate People's Court dismissed the claims made by Guangdong Nanyue Bank against the company, stating that the bank failed to verify the public disclosure of the guarantee matters [3][5]. - The court supported the company's defense regarding the "maximum pledge contract," ruling that it does not have legal effect, thus not impacting the company's current or future profits [3][5].